STOCKSCREENR

ETON

NASDAQ

Eton Pharmaceuticals, Inc.

$18.92-0.09(-0.47%)Mkt Cap: $507.39M

Key Stats

Market Cap

$507.39M

P/E Ratio

-72.77

EPS

$-0.26

Dividend Yield

0.00%

52-Week Range

$11.09 — $23.00

Volume

223.19K

Avg Volume

256.46K

Beta

1.24

Valuation

P/E (TTM)

-72.77

Forward P/E

18.67

PEG Ratio

1.15

P/S (TTM)

7.25

P/B (TTM)

22.12

P/FCF

EV/EBITDA

EV/Sales

Financial Health

ROE (TTM)

-0.28%

ROA (TTM)

-0.06%

ROIC

Gross Margin

0.51%

Operating Margin

-0.04%

Net Margin

Debt/Equity

0.14

Current Ratio

1.63

Growth

EPS Growth (YoY)

Revenue Growth (YoY)

EPS Growth (3Y)

-1.95%

EPS Growth (5Y)

-1.04%

Sales Growth (3Y)

+0.23%

Sales Growth (5Y)

+111.71%

EPS Est (This Year)

$1.01

EPS Est (Next Year)

$1.61

Dividends

Dividend Yield

Annual Dividend

Payout Ratio

Frequency

Ex-Dividend Date

Cash/Share

$1.38

Analyst Consensus

Price Target Range

$15.00$25.00$35.00
LowMedianHigh

Consensus Target: $25.00(32.1% upside)

Ownership

Institutional %

Inst. Net Change

Insider Net Shares (90d)

Outstanding Shares

26.82M

Float

22.71M

Free Float %

84.69%

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

IPO Date

2018-11-13

Employees

31

CEO

Sean E. Brynjelsen

Index Membership

Website

https://www.etonpharma.com

Eton Pharmaceuticals, Inc. (ETON) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $507.39M, a P/E ratio of -72.77, ETON is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ETON against other stocks using dozens of fundamental and technical filters.

Similar Stocks

Frequently Asked Questions

What is Eton Pharmaceuticals, Inc.'s P/E ratio?

Eton Pharmaceuticals, Inc. (ETON) has a trailing twelve-month (TTM) P/E ratio of -72.77. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Eton Pharmaceuticals, Inc. pay a dividend?

No, Eton Pharmaceuticals, Inc. (ETON) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Eton Pharmaceuticals, Inc.'s market cap?

Eton Pharmaceuticals, Inc. (ETON) has a market capitalization of $507.39 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.